Toward alpha‐synuclein seed amplification assay in clinical practice

Abstract INTRODUCTION Seed amplification assays (SAAs) demonstrate remarkable diagnostic performance in alpha‐synucleinopathies. However, existing protocols lack accessibility in routine laboratories, mainly due to the requirement for in‐house production of recombinant alpha‐synuclein (aSyn). This s...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Mathieu Verdurand, Flora Kaczorowski, Sophie Dautricourt, Virginie Desestret, Maïté Formaglio, Hélène Mollion, Gil Petitnicolas, Ali Afifi, Anthony Fourier, Antoine Garnier‐Crussard, Isabelle Quadrio
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2025-01-01
Serie:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Soggetti:	alpha‐synuclein (α‐synuclein) aSyn biomarker brain homogenate (BH) cerebrospinal fluid (CSF) dementia with Lewy bodies (DLB)
Accesso online:	https://doi.org/10.1002/dad2.70066
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!